Jason Lai's questions to Myriad Genetics Inc (MYGN) leadership • Q2 2025
Question
Jason Lai of Morgan Stanley, on for Yuko Oku, asked about the market traction of the Prequel NIPS test since its launch, specifically whether its performance has met expectations and if its differentiated 8-week gestational age feature has resulted in market share gains.
Answer
COO Mark Verratti responded that the company is 'excited about the launch' and has seen 'tremendous uptake' for Prequel. He attributed this to the 8-week offering fitting 'very nicely within workflows' as it aligns with a patient's first prenatal visit. While he noted that quantifying specific market share gains is challenging, the company has observed an increase in volume from the test being ordered earlier.